United States · Bill · HR
H.R. 5382 (116th)
To create a mechanism whereby insulin manufacturers may sell directly to consumers at current net prices.
Introduced
10 December 2019
Last action
—
Status
Referred to the Subcommittee on Health.
Sponsors
—
Subjects
Discovery layer
Source updated
3 January 2025
Summary
This bill requires the federal government to create a mechanism through which insulin manufacturers may sell their products directly to consumers at current net prices.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
3 official files
Introduced in House (text)
Introduced in House (text)
Introduced in House · EN · 10 December 2019
Introduced in House (PDF)
Introduced in House · EN · 10 December 2019
Introduced in House
summary · EN · 10 December 2019
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/116th-congress/house-bill/5382
- Open data entity: https://api.congress.gov/v3/bill/116/hr/5382